INTRODUCTION AND OBJECTIVES: Thrombomodulin (TM) extensively expresses on the endothelial cells in the steady state and is known to prevent hypercoagulation via combining with thrombin and inactivating its procoagulant activity. TM also has anti-inflammatory effects. In inflammatory situation including ischemia reperfusion injury TM is known to be detached from the endothelial cells. The purpose of this study is to investigate whether perfusate solution saturated with recombinant TM alpha (rTM) can attenuate kidney graft damage after long cold ischemia time.
METHODS: We employed a rat syngeneic kidney transplant model using Lewis strain. Donor kidney grafts were preserved in a cold UW perfusate solution saturated with rTM (Group A, n[7), or not (Group B, n[8) for 24 hours. Then kidney transplantation (Lewis to Lewis) was performed. Blood and urine samples were sequentially collected (post operative day 1, 2, and 7) to measure creatinine clearance. Neutrophil gelatinase-associated lipocalin (NGAL), an acute kidney injury marker, was also measured by ELISA. Kidney graft samples in an acute phase (2 hours after operation) were collected to investigate the grade of tubular damage. TUNEL assay by immunofluorescence was performed. Immunohistochemistry (IHC) for TM was also performed.
RESULTS: IHC revealed that the expression of TM on kidney grafts after 24-hour cold ischemia was extensively reduced compared with those after 0-hour ischemia. Creatinine clearance (ml/min/kg) in Group A was significantly ameliorated compared with that in Group B: mean AE se of Group A vs Group B; 0.68 AE 0 .09 vs 0.23 AE 0 .09 on POD 1; 1.22 AE 0.40 vs 0.59 AE 0.30 on POD 2; and 2.63 AE 1.42 vs 1.17 AE 0.69 on POD 7; p[0.02, two-way repeated measured ANOVA. Serum levels of NGAL (ï g/ml) in Group A were significantly lower than those in Group B: mean AE se of Group A vs Group B; 6.5 AE 1.7 vs 9.1 AE 1.1 on POD 1; and 4.3 AE 1.1 vs 8.9 AE 0.8 on POD 2; p[0.02, two-way repeated measured ANOVA. Fewer damaged tubular cells and apoptosis positive cells at a very acute phase were observed in Group A, compared with in Group B.
CONCLUSIONS: Perfusion with rTM significantly attenuates kidney graft damage after long cold ischemia time by abrogating apoptosis in tubular cells.
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Dae Keun Kim*, A Ra Jung, Jung Ki Jo, Seoul, Korea, Republic of; Hyung Ho Lee, Goyang, Korea, Republic of; Joon Chae Na, Woong Kyu Han, Sung Yul Park, Hong Sang Moon, Young Eun Yoon, Seoul, Korea, Republic of INTRODUCTION AND OBJECTIVES: CORM-3 has organ protective effect in ischemic or inflammatory conditions. Using a singlekidney rat model, we evaluated renoprotective function of injection of CORM-3 in renal ischemia reperfusion injury.
METHODS: The rats were randomly divided into three groups; sham (right nephrectomy), control (right nephrectomy and left renal ischemia), and CORM-3 (right nephrectomy and CORM-3 injection before left renal ischemia). For renal ischemia and reperfusion injury, just after right nephrectomy, we clamped left renal vessels for 30 to 90 minutes. In CORM-3 group, CORM-3 10mg was injected via caudal artery, followed by left renal artery clamping 1 hour later. After sacrifice of animals, kidney tissues and blood samples were evaluated to determine the renoprotective effect of CORM-3.
RESULTS: Serum creatinine at one day after ischemia reperfusion showed ischemia time dependent increasements. In 30 minutes and 45 minutes experiments, there was no significant difference between the groups because of not enough renal damage, but in IRI injuries more than 60 minutes, CORM-3 group showed lower serum creatinine than control group. In the pathological review of the kidney tissues, the normal tubules and glomerulus were more conserved in the CORM-3 group. TUNEL staining showed fewer apoptotic renal tubular cells in the CORM-3 group compared with control.
CONCLUSIONS: Pretreatment with CORM-3 injection before renal ischemia reperfusion injury showed renoprotective effect. This could be a new strategy against renal ischemia reperfusion injury in partial nephrectomy or kidney transplantation. Vol. 201, No. 4S, Supplement, Monday, May 6, 2019 THE JOURNAL OF UROLOGY Ò e1123
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